News of the index components OMX Copenhagen 20

Index

OMXC20

DK0016268840

Market Closed - Nasdaq Copenhagen 16:05:00 05/07/2024 BST			5-day change	1st Jan Change
2,845 ^PTS	+0.24%		-1.49%	+24.57%

07-02	Indices: CAC relaxes, Merval soars
06-05	Nordic Shares Moved Upward Wednesday; Crayon Group Topped Leaders	DJ

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Novo Nordisk A/S, Q1 2024 Earnings Call, May 02, 2024 NOVO B	05-02
Wind farm developer Orsted confident about strategy after Q1 profit rises ORSTED	05-02	RE
NOVO NORDISK : JP Morgan gives a Buy rating NOVO B	05-02	ZD
Pandora: solid first quarter, 2024 forecasts raised PNDORA	05-02	CF
Danske Bank A/S : Major Execution Venues and Brokers - Danske Bank AS DANSKE	05-02	PU
Novo Nordisk: EPS up 29% in Q1 NOVO B	05-02	CF
Danske Bank A/S : Remuneration to Material Risk Takers 2023 DANSKE	05-02	PU
NOVO NORDISK : Receives a Sell rating from Jefferies NOVO B	05-02	ZD
Novo Nordisk: Q1 Earnings Snapshot NOVO B	05-02	AQ
Danske Bank A/S, transactions by persons discharging managerial responsibilities DANSKE	05-02	GL
Transcript : GN Store Nord A/S, Q1 2024 Earnings Call, May 02, 2024 GN	05-02
Transcript : A.P. Møller - Mærsk A/S, Q1 2024 Earnings Call, May 02, 2024 MAERSK B	05-02
Pandora Raises FY24 Guidance on Q1 Revenue Growth PNDORA	05-02	MT
Novo Nordisk will continue to manage Wegovy starter doses, CFO says NOVO B	05-02	RE
Orsted Not Currently Planning To Use Chinese Wind Turbines, CEO Says ORSTED	05-02	RE
Transcript : Pandora A/S, Q1 2024 Earnings Call, May 02, 2024 PNDORA	05-02
Transcript : ISS A/S, Q1 2024 Sales/ Trading Statement Call, May 02, 2024 ISS	05-02
Notification and public disclosure of transactions in Carlsberg A/S shares by persons discharging managerial responsibilities CARL B	05-02	AQ
Correction: Ørsted Posts Lower Q1 Attributable Profit, Revenue ORSTED	05-02	MT
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating -- Update NOVO B	05-02	DJ
Orsted Backs 2024 Guidance After Earnings Decline ORSTED	05-02	DJ
Maersk Raises Guidance as Overcapacity Issues Persist MAERSK B	05-02	DJ
Novo Nordisk says US price of Wegovy fell slightly in Q1 NOVO B	05-02	RE
Vegfinans Innlandet AS - Contemplating new NOK bond issuance DANSKE	05-02	AQ
Ørsted Posts Lower Q1 Attributable Profit, Revenue ORSTED	05-02	MT
Wind power giant Orsted Q1 operating profit meets expectations ORSTED	05-02	RE
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating NOVO B	05-02	DJ
Orsted A/S : Interim report for the first quarter of 2024 - Operating profit in line with expectations, with offshore site earnings increasing 18 %. Business plan progressing with Sunrise Wind award and completion of two offshore wind farms ORSTED	05-02	PU
Maersk posts Q1 profits above expectations, lifts lower end of FY guidance range MAERSK B	05-02	RE
Interim report for the first quarter of 2024 – Operating profit in line with expectations, with offshore site earnings increasing 18 %. Business plan progressing with Sunrise Wind award and completion of two offshore wind farms ORSTED	05-02	EQ
Interim report for the first quarter of 2024 – Operating profit in line with expectations, with offshore site earnings increasing 18 %. Business plan progressing with Sunrise Wind award and completion of two offshore wind farms ORSTED	05-02	AQ
Interim Report Q1 2024 MAERSK B	05-02	AQ
A.P. Møller - Mærsk A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 MAERSK B	05-02	CI
Ørsted A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 ORSTED	05-02	CI
Novo Nordisk Reports Higher Q1 Net Profit, Net Sales NOVO B	05-02	MT
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast NOVO B	05-02	RE
Pandora A/S : delivers 18% organic growth in Q1 - raises 2024 revenue guidance PNDORA	05-02	PU
Pandora Q1 beats expectations, ups guidance PNDORA	05-02	RE
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast NOVO B	05-02	RE
Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024 NOVO B	05-02	GL